Ladenburg, Germany, 21 March 2025 – Heidelberg Pharma AG (FSE: HPHA) today published its financial results and Annual Report for fiscal year 2024 (1 December 2023 – 30 November 2024) and its outlook ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...

U.S. News & World Report: Calling The Shots: Tracking Robert F. Kennedy Jr.'s Moves On Vaccines Since taking the helm of HHS, Robert F. Kennedy Jr. has both backed vaccination as a public health ...

Optum Rx is shifting its payment models to better meet the needs of pharmacies and consumers, the pharmacy benefit manager ...

The massive PBM is pivoting to a cost-based reimbursement model, which it says will reduce variation in how pharmacies are paid. Pharmacy groups say that depends on the specifics of Optum Rx’s plan.

Alnylam’s drug, vutrisiran, was approved for patients with transthyretin amyloid cardiomyopathy, or ATTR-CM, to reduce ...

Telix Pharmaceuticals' said its new drug application in the U.S. for an imaging agent received regulatory approval. The Melbrourne, Australia-based biopharmaceutical company said Friday that the Food ...

Foran Mining Corporation ("Foran" or the "Company") has filed its annual financial results for the year ended December 31, 2024. The Company's consolidated financial statements, management's ...

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current ...

Whether you're looking to stop your sugar cravings or cut sugar out of your diet, these simple tricks will help you reach ...